Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Autocrine IL-8 promotes F-actin polymerization and mediate mesenchymal transition via ELMO1-NF-?B-Snail signaling in glioma. Zhang B, Shi L, Lu S, Sun X, Liu Y, Li H, Wang X, Zhao C, Zhang H, Wang Y. Cancer biology & therapy. 2015 16:898-911. (IHC, WB; Human)[Full Text Article]
CXCR2 Antibody, CDw128b Antibody, CD182 antigen Antibody, CMKAR2 Antibody, CXCR-2 Antibody, CD182 Antibody, CXC-R2 Antibody, IL-8R B Antibody, Il-8 receptor b Antibody, IL-8 receptor type 2 Antibody, Il-8rb Antibody, IL8R2 Antibody, IL8RB Antibody, Interleukin-8 receptor type B Antibody, GRO/MGSA receptor Antibody, Interleukin 8 receptor beta Antibody, Interleukin 8 receptor, beta Antibody, Chemokine (CXC) receptor 2 Antibody, IL8RA Antibody, Interleukin 8 receptor B Antibody, Interleukin 8 receptor type 2 Antibody
CXCR2 is a member of the G-protein-coupled receptor family. This protein is a receptor for interleukin 8 (IL8). It binds to IL8 with high affinity, and transduces the signal through a G-protein activated second messenger system. This receptor also binds to chemokine (C-X-C motif) ligand 1 (CXCL1/MGSA), a protein with melanoma growth stimulating activity, and has been shown to be a major component required for serum-dependent melanoma cell growth.